Location History:
- Madrid, ES (2013)
- Toledo, ES (2013 - 2017)
Company Filing History:
Years Active: 2013-2017
Title: Innovations by Francisca Delgado-Jiménez in Beta-Secretase Inhibitors
Introduction
Francisca Delgado-Jiménez, hailing from Toledo, Spain, is a notable inventor with a significant contribution to the field of pharmaceuticals. With five patents to her name, her work primarily focuses on compounds targeting beta-secretase, an enzyme critical in various neurodegenerative disorders, including Alzheimer's disease.
Latest Patents
Among her latest innovations, Francisca has developed substituted 3,4-dihydropyrrolo[1,2-A]pyrazines. These compounds serve as beta-secretase (BACE) inhibitors, offering potential therapeutic solutions for disorders linked to this enzyme. Her patent describes novel derivatives of formula (I), defined in her specification, along with pharmaceutical compositions containing these compounds. The therapeutic applications extend to conditions such as Alzheimer's disease, senility, and multiple forms of dementia.
Another noteworthy patent highlights 5,6-dihydro-imidazo[1,2-a]pyrazin-8-ylamine derivatives as effective inhibitors of beta-secretase. Like the previous inventions, this patent outlines specific structures defined in her specifications and emphasizes their potential use in preventing and treating various cognitive impairments associated with beta-secretase activity.
Career Highlights
Francisca Delgado-Jiménez works for Janssen Pharmaceutica NV, where she applies her expertise in medicinal chemistry and pharmaceutical innovation to develop effective treatments for challenging health issues. Her patents reflect her commitment to advancing science and providing solutions for critical medical needs.
Collaborations
Throughout her career, Francisca has collaborated with esteemed colleagues, including Andrés Avelino Trabanco-Suárez and Gary John Tresadern. These partnerships enhance her research endeavors and promote innovation within the realms of pharmacology and biochemistry.
Conclusion
Francisca Delgado-Jiménez represents a pivotal figure in pharmaceutical innovation, particularly concerning beta-secretase inhibitors. Her ongoing work contributes significantly to the understanding and treatment of neurodegenerative diseases, underscoring the power of inventive solutions in addressing global health challenges.